Aktie A0M3SU NORTH CHINA PHARMACEUTICAL COMPANY.LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen North China Pharmaceutical Company.Ltd

Aktien

A0M3SU

CNE000000D16

600812

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 09.05.2024 		% 5 Tage % 1. Jan.
5,31 CNY 0,00 % Intraday Chart für North China Pharmaceutical Company.Ltd +2,51 % -6,84 %
25.04. North China Pharmaceutical Company.Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
29.03. North China Pharmaceutical Company.Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 beendete Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd
North China Pharmaceutical Gets Nod to Market Ampicillin API
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
North China Pharma Unit Passes Compliance Inspection
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M3SU Aktie
  4. Nachrichten North China Pharmaceutical Company.Ltd
  5. Andere Sprachen